The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

GSK is closing down a facility and is winding down antibiotic manufacturing operations at another factory as Novartis’ Sandoz ...

With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...

It is believed about 200 roles will be cut at the facility in Barnard Castle, County Durham, in October 2025. The team ...

The site in Ulverston, Cumbria, has been producing the antibiotic Zinnat for the Swiss-owned firm Sandoz. In 2021, GSK said ...

UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...

If I did not have it, I would certainly use this dip to buy the stock, given its extreme undervaluation and excellent growth prospects. The post With GSK’s share price down 9%, is it time for me to ...

GSK recently reported that its asthma drug Nucala (mepolizumab) met the primary endpoint in a Phase III trial treating ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of ...

GSK today announced positive headline results of MATINEE, the Phase III clinical trial evaluating its asthma drug Nucala ...

GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a ...

GSK has confirmed plans to sell its Horlicks business in the UK and close the site where the malted drink is made. As well as shutting the site in Slough, the pharmaceuticals giant said it will ...